title: Chronically KIT-stimulated clonally-derived human mast cells show heterogeneity in different tissue microenvironments.
abstract: Human mast cell precursors arise in the bone marrow and circulate to different tissue microenvironments, where they develop distinct phenotypes that may be characterized by differential expression of the serine protease, chymase. The growth and development of mast cells is stimulated by mast cell growth factor, which is also known as kit ligand because its obligate receptor is KIT, the protein product of the c-KIT proto-oncogene. The in vivo influence of the KIT-kit ligand axis on the phenotype of human mast cells has not been determined. We used immunohistochemistry to detect in situ expression of tryptase and chymase by mast cells of a patient with urticaria pigmentosa and aggressive systemic mastocytosis, whose pathologic mast cells are clonally derived and chronically stimulated by KIT because they all contain the same point mutation causing constitutive activation of KIT. Mast cells in both spleen and skin expressed tryptase, but only in the skin did a majority of mast cells express chymase. We conclude that chronic stimulation of the KIT-kit ligand axis does not irrevocably commit mast cells to a chymase-positive or chymase-negative phenotype. These findings suggest that factors other than kit ligand predominate in determining mast cell phenotype.
authors.affiliation: Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut 06520-8059, USA.
authors.forename: B J
authors.initials: BJ
authors.lastname: Longley
authors.forename: L
authors.initials: L
authors.lastname: Tyrrell
authors.forename: S
authors.initials: S
authors.lastname: Lu
authors.forename: Y
authors.initials: Y
authors.lastname: Ma
authors.forename: V
authors.initials: V
authors.lastname: Klump
authors.forename: G F
authors.initials: GF
authors.lastname: Murphy
mesh_terms: D053818:Chymases; D002999:Clone Cells / Q000166:cytology; D018740:Genetic Heterogeneity; D006801:Humans; D008297:Male; D008407:Mast Cells / Q000166:cytology* / Q000187:drug effects / Q000378:metabolism; D008415:Mastocytosis / Q000473:pathology; D008875:Middle Aged; D010641:Phenotype; D017354:Point Mutation; D000090063:Proto-Oncogene Mas; D019009:Proto-Oncogene Proteins c-kit / Q000235:genetics / Q000494:pharmacology*; D012697:Serine Endopeptidases / Q000096:biosynthesis; D012867:Skin / Q000166:cytology; D013154:Spleen / Q000166:cytology; D053802:Tryptases; D014582:Urticaria Pigmentosa / Q000473:pathology
chemical_list: C000715470:MAS1 protein, human; D000090063:Proto-Oncogene Mas; D019009:Proto-Oncogene Proteins c-kit; D012697:Serine Endopeptidases; C083294:chymase 2; D053818:Chymases; D053802:Tryptases